BANK VONTOBEL/CALL/ELI LILLY & CO/820/0.1/21.06.24 Share Price

Warrant

DE000VM92QN2

Market Closed - Deutsche Boerse AG 11:23:46 14/06/2024 pm IST
5.77 EUR +1.58% Intraday chart for BANK VONTOBEL/CALL/ELI LILLY & CO/820/0.1/21.06.24
Current month+197.42%
1 month+659.21%
Date Price Change
14/24/14 5.77 +1.58%
13/24/13 5.68 +24.29%
12/24/12 4.57 +4.10%
11/24/11 4.39 +0.46%
10/24/10 4.37 +7.37%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 11:23 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VM92QN
ISINDE000VM92QN2
Date issued 08/02/2024
Strike 820 $
Maturity 21/06/2024 (5 Days)
Parity 10 : 1
Emission price 2.12
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 6.75
Lowest since issue 0.64
Delta0.96x
Omega 14.11
Premium0.16x
Gearing14.68x
Moneyness 1.071
Difference Strike -58.45 $
Difference Strike %-7.13%
Spread 0.02
Spread %0.36%
Intrinsic value 5.468

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
878.4 USD
Average target price
855.4 USD
Spread / Average Target
-2.63%
Consensus